CompletedNCT00543088
Antipsychotic treatment and quality of life in schizophrenia or bipolarity
About this title
Read the official source — NCT00543088Observational studyAges 18–65Belgium
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Baudour and 56 more locationsSee all locations and recruitment
Study information
Study start dateJanuary 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 250
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- Belgium
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00543088
- Official title
Show the full official title
SERENITY: Evaluating the Effectiveness of Atypical Antipsychotics in the Community - a Prospective, Multicentre, Observational Study to Evaluate the Impact on Quality of Life of GP-Bases Management of Antipsychotic Treatment in Belgium.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baudour · Beyne-Heysay · Bomal
54 more locations
- Bredene
- Brussels
- Esen
- Evere
- Gingelom
- Gouy-lez-Piéton
- Grâce-Hollogne
- Gullegem
- Harelbeke
- Harre
- Hotton
- Houtvenne
- Incourt
- Ixelles-Elsene
- Jalhay
- Jette
- Keumiée
- Lembeke
- Liège
- Limbourg
- Longueville
- Lovendegem
- Malmedy
- Mechelen
- Monceau-sur-Sambre
- Montignies-sur-Sambre
- Moorsel
- Moorseled
- Mouscron
- Namur
- Oostrozebeke
- Ostend
- Oudenaarde
- Poperinge
- Ransart
- Roux
- Ruisbroek
- Schaarbeek
- Spa
- Staden
- Theux
- Tilleur
- Torhout
- Tubize
- Verviers
- Veurne
- Wachtebeke
- Willebroek
- Wilrijk
- Woluwe-St-Lambert
- Zeebrugge
- Zichem
- Zomergem
- Zonnebeke
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: 18 years to 65 years.
